
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $27.8B | $46.2B | $50.5B | $41.1B | $40.3B | |
Revenue Growth (YoY) | -20.08% | 66.37% | 9.27% | -18.52% | -1.96% | |
Cost of Revenues | $24.4B | $37.4B | $43.8B | $35.8B | $35.7B | |
Gross Profit | $3.4B | $8.8B | $6.6B | $5.3B | $4.6B | |
Gross Profit Margin | 12.23% | 19.01% | 13.09% | 12.79% | 11.33% | |
R&D Expenses | $113M | $124M | $124M | $130M | $135M | |
Selling, General & Admin | $1.1B | $1.3B | $1.3B | $1.6B | $1.7B | |
Other Inc / (Exp) | -$241M | -$101M | -$136M | -$596M | -$832M | |
Operating Expenses | $1.3B | $1.4B | $1.4B | $1.7B | $1.8B | |
Operating Income | $2.1B | $7.4B | $5.2B | $3.6B | $2.8B | |
Net Interest Expenses | $514M | $510M | $258M | $348M | $331M | |
EBT. Incl. Unusual Items | $1.4B | $6.8B | $4.8B | $2.6B | $1.6B | |
Earnings of Discontinued Ops. | -$2M | -$6M | -$5M | -$5M | $4M | |
Income Tax Expense | -$43M | $1.2B | $882M | $501M | $240M | |
Net Income to Company | $1.4B | $5.6B | $3.9B | $2.1B | $1.4B | |
Minority Interest in Earnings | -$7M | -$7M | -$7M | -$7M | -$7M | |
Net Income to Common Excl Extra Items | $1.4B | $5.6B | $3.9B | $2.1B | $1.4B | |
Basic EPS (Cont. Ops) | $4.24 | $16.77 | $11.84 | $6.48 | $4.16 | |
Diluted EPS (Cont. Ops) | $4.24 | $16.75 | $11.81 | $6.46 | $4.15 | |
Weighted Average Basic Share | $334M | $334M | $327M | $325M | $325M | |
Weighted Average Diluted Share | $334M | $334M | $328M | $326M | $326M | |
EBITDA | $3.3B | $8.7B | $6.3B | $4.6B | $3.6B | |
EBIT | $1.9B | $7.3B | $5.1B | $3.1B | $2.1B | |
Revenue (Reported) | $27.8B | $46.2B | $50.5B | $41.1B | $40.3B | |
Operating Income (Reported) | $2.1B | $7.4B | $5.2B | $3.6B | $2.8B | |
Operating Income (Adjusted) | $1.9B | $7.3B | $5.1B | $3.1B | $2.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $9.1B | $13.2B | $10.2B | $8.3B | $7.7B | |
Revenue Growth (YoY) | 21.19% | 44.87% | -22.12% | -18.96% | -7.55% | |
Cost of Revenues | $7.7B | $11.1B | $8.9B | $7.2B | $7.1B | |
Gross Profit | $1.4B | $2B | $1.4B | $1.1B | $549M | |
Gross Profit Margin | 15.46% | 15.36% | 13.5% | 13.3% | 7.15% | |
R&D Expenses | $29M | $32M | $33M | $32M | $34M | |
Selling, General & Admin | $287M | $328M | $385M | $421M | $401M | |
Other Inc / (Exp) | $162M | $48M | -$230M | -$22M | $22M | |
Operating Expenses | $316M | $360M | $418M | $453M | $435M | |
Operating Income | $1.1B | $1.7B | $965M | $651M | $114M | |
Net Interest Expenses | $108M | $72M | $93M | $86M | $77M | |
EBT. Incl. Unusual Items | $1.1B | $1.6B | $642M | $543M | $59M | |
Earnings of Discontinued Ops. | -$2M | -$1M | -$1M | $40M | $154M | |
Income Tax Expense | $70M | $316M | $167M | $110M | $36M | |
Net Income to Company | $1.1B | $1.3B | $474M | $473M | $177M | |
Minority Interest in Earnings | -$2M | -$2M | -$2M | -$2M | -$2M | |
Net Income to Common Excl Extra Items | $1.1B | $1.3B | $472M | $471M | $175M | |
Basic EPS (Cont. Ops) | $3.19 | $4.01 | $1.45 | $1.45 | $0.54 | |
Diluted EPS (Cont. Ops) | $3.18 | $4.00 | $1.44 | $1.44 | $0.54 | |
Weighted Average Basic Share | $334M | $328M | $326M | $325M | $324M | |
Weighted Average Diluted Share | $334M | $329M | $327M | $326M | $324M | |
EBITDA | $1.6B | $2B | $1.2B | $1B | $489M | |
EBIT | $1.3B | $1.7B | $758M | $670M | $166M | |
Revenue (Reported) | $9.1B | $13.2B | $10.2B | $8.3B | $7.7B | |
Operating Income (Reported) | $1.1B | $1.7B | $965M | $651M | $114M | |
Operating Income (Adjusted) | $1.3B | $1.7B | $758M | $670M | $166M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $29.3B | $50.2B | $47.5B | $39.2B | $38.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $25.2B | $40.9B | $41.6B | $34.2B | $34.1B | |
Gross Profit | $4.2B | $9.4B | $6B | $5B | $4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $115M | $127M | $125M | $129M | $137M | |
Selling, General & Admin | $1.1B | $1.3B | $1.4B | $1.6B | $1.6B | |
Other Inc / (Exp) | -$79M | -$215M | -$414M | -$388M | -$788M | |
Operating Expenses | $1.2B | $1.4B | $1.5B | $1.7B | $1.8B | |
Operating Income | $2.9B | $8B | $4.5B | $3.3B | $2.2B | |
Net Interest Expenses | $536M | $474M | $279M | $341M | $322M | |
EBT. Incl. Unusual Items | $2.3B | $7.3B | $3.8B | $2.5B | $1.1B | |
Earnings of Discontinued Ops. | -$5M | -$5M | -$5M | $36M | $159M | |
Income Tax Expense | -$48M | $1.4B | $733M | $444M | $154M | |
Net Income to Company | $2.4B | $5.9B | $3B | $2.1B | $1.1B | |
Minority Interest in Earnings | -$7M | -$7M | -$7M | -$2M | -$1M | |
Net Income to Common Excl Extra Items | $2.3B | $5.9B | $3B | $2.1B | $1.1B | |
Basic EPS (Cont. Ops) | $7.01 | $17.59 | $9.28 | $6.48 | $3.26 | |
Diluted EPS (Cont. Ops) | $7.00 | $17.56 | $9.24 | $6.47 | $3.25 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $4.2B | $9.1B | $5.5B | $4.5B | $3B | |
EBIT | $2.9B | $7.8B | $4.1B | $3B | $1.5B | |
Revenue (Reported) | $29.3B | $50.2B | $47.5B | $39.2B | $38.1B | |
Operating Income (Reported) | $2.9B | $8B | $4.5B | $3.3B | $2.2B | |
Operating Income (Adjusted) | $2.9B | $7.8B | $4.1B | $3B | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $9.1B | $13.2B | $10.2B | $8.3B | $7.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $7.7B | $11.1B | $8.9B | $7.2B | $7.1B | |
Gross Profit | $1.4B | $2B | $1.4B | $1.1B | $549M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $29M | $32M | $33M | $32M | $34M | |
Selling, General & Admin | $287M | $328M | $385M | $421M | $401M | |
Other Inc / (Exp) | $162M | $48M | -$230M | -$22M | $22M | |
Operating Expenses | $316M | $360M | $418M | $453M | $435M | |
Operating Income | $1.1B | $1.7B | $965M | $651M | $114M | |
Net Interest Expenses | $108M | $72M | $93M | $86M | $77M | |
EBT. Incl. Unusual Items | $1.1B | $1.6B | $642M | $543M | $59M | |
Earnings of Discontinued Ops. | -$2M | -$1M | -$1M | $40M | $154M | |
Income Tax Expense | $70M | $316M | $167M | $110M | $36M | |
Net Income to Company | $1.1B | $1.3B | $474M | $473M | $177M | |
Minority Interest in Earnings | -$2M | -$2M | -$2M | -$2M | -$2M | |
Net Income to Common Excl Extra Items | $1.1B | $1.3B | $472M | $471M | $175M | |
Basic EPS (Cont. Ops) | $3.19 | $4.01 | $1.45 | $1.45 | $0.54 | |
Diluted EPS (Cont. Ops) | $3.18 | $4.00 | $1.44 | $1.44 | $0.54 | |
Weighted Average Basic Share | $334M | $328M | $326M | $325M | $324M | |
Weighted Average Diluted Share | $334M | $329M | $327M | $326M | $324M | |
EBITDA | $1.6B | $2B | $1.2B | $1B | $489M | |
EBIT | $1.3B | $1.7B | $758M | $670M | $166M | |
Revenue (Reported) | $9.1B | $13.2B | $10.2B | $8.3B | $7.7B | |
Operating Income (Reported) | $1.1B | $1.7B | $965M | $651M | $114M | |
Operating Income (Adjusted) | $1.3B | $1.7B | $758M | $670M | $166M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.8B | $1.5B | $2.2B | $3.4B | $3.4B | |
Short Term Investments | $702M | $9M | -- | -- | -- | |
Accounts Receivable, Net | $3.3B | $4.6B | $3.4B | $3.4B | $3.1B | |
Inventory | $4.3B | $4.9B | $4.8B | $4.8B | $4.7B | |
Prepaid Expenses | $152M | $90M | $93M | $126M | $119M | |
Other Current Assets | $141M | $403M | $559M | $239M | $341M | |
Total Current Assets | $11.6B | $12.2B | $11.8B | $13.2B | $12.3B | |
Property Plant And Equipment | $15.9B | $16.5B | $17.1B | $17.1B | $16.5B | |
Long-Term Investments | $4.7B | $4.8B | $4.3B | $3.9B | $4.1B | |
Goodwill | $2B | $1.9B | $1.8B | $1.6B | $1.6B | |
Other Intangibles | $751M | $695M | $662M | $641M | $577M | |
Other Long-Term Assets | $81M | $83M | $199M | $249M | $252M | |
Total Assets | $35.4B | $36.7B | $36.4B | $37B | $35.7B | |
Accounts Payable | $2.4B | $4.3B | $3.6B | $3.8B | $3.7B | |
Accrued Expenses | $783M | $1.2B | $1.2B | $980M | $908M | |
Current Portion Of Long-Term Debt | $171M | $164M | $581M | $899M | $617M | |
Current Portion Of Capital Lease Obligations | $310M | $336M | $344M | $360M | $355M | |
Other Current Liabilities | $334M | $251M | $232M | $594M | $360M | |
Total Current Liabilities | $5.5B | $7.2B | $6.8B | $7.2B | $6.7B | |
Long-Term Debt | $15.3B | $11.2B | $10.5B | $10.3B | $10.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $27.3B | $24.8B | $23.6B | $23.9B | $23.2B | |
Common Stock | $19M | $19M | $19M | $19M | $19M | |
Other Common Equity Adj | -$1.9B | -$1.8B | -$1.4B | -$1.5B | -$1.5B | |
Common Equity | $8B | $11.9B | $12.6B | $12.9B | $12.5B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $133M | $130M | $128M | $128M | $126M | |
Total Equity | $8.1B | $12B | $12.7B | $13.1B | $12.6B | |
Total Liabilities and Equity | $35.4B | $36.7B | $36.4B | $37B | $35.7B | |
Cash and Short Terms | $2.5B | $1.5B | $2.2B | $3.4B | $3.4B | |
Total Debt | $16B | $11.6B | $11.3B | $11.2B | $11.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.5B | $1.8B | $1.8B | $2.3B | $1.9B | |
Short Term Investments | $383M | -- | -- | -- | -- | |
Accounts Receivable, Net | $4B | $5.1B | $3.7B | $4B | $3.6B | |
Inventory | $4.6B | $5B | $5.2B | $4.9B | $4.9B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.5B | $1.1B | $1.2B | $1.5B | $809M | |
Total Current Assets | $12B | $13.3B | $12B | $12.9B | $11.4B | |
Property Plant And Equipment | $15.9B | $16.6B | $17.1B | $17B | $16.9B | |
Long-Term Investments | $4.8B | $4.7B | $4.3B | $3.8B | $4.1B | |
Goodwill | $1.9B | $1.9B | $1.6B | $1.6B | $1.6B | |
Other Intangibles | $717M | $673M | $651M | $631M | $580M | |
Other Long-Term Assets | $511M | $647M | $631M | $632M | $639M | |
Total Assets | $35.7B | $37.9B | $36.3B | $36.6B | $35.2B | |
Accounts Payable | $3.3B | $5B | $3.6B | $4B | $3.7B | |
Accrued Expenses | $2B | $2.4B | $2.2B | $1.9B | $2B | |
Current Portion Of Long-Term Debt | $1.1B | $114M | $575M | $171M | $615M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $6.9B | $7.5B | $6.5B | $6.1B | $6.2B | |
Long-Term Debt | $13.8B | $11.2B | $10.6B | $11B | $10.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $26.8B | $25B | $23.4B | $23.5B | $22.9B | |
Common Stock | $19M | $19M | $19M | $19M | $19M | |
Other Common Equity Adj | -$1.9B | -$1.7B | -$1.3B | -$1.5B | -$1.4B | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $130M | $130M | $128M | $128M | $126M | |
Total Equity | $8.9B | $12.8B | $12.8B | $13.1B | $12.3B | |
Total Liabilities and Equity | $35.7B | $37.9B | $36.3B | $36.6B | $35.2B | |
Cash and Short Terms | $1.8B | $1.8B | $1.8B | $2.3B | $1.9B | |
Total Debt | $15.4B | $11.3B | $11.4B | $11.2B | $11.2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.4B | $5.6B | $3.9B | $2.1B | $1.4B | |
Depreciation & Amoritzation | $1.4B | $1.4B | $1.3B | $1.5B | $1.5B | |
Stock-Based Compensation | $55M | $66M | $70M | $91M | $91M | |
Change in Accounts Receivable | -$246M | -$1.5B | $1B | $110M | $127M | |
Change in Inventories | $340M | -$742M | -$91M | $18M | $25M | |
Cash From Operations | $3.4B | $7.7B | $6.1B | $4.9B | $3.8B | |
Capital Expenditures | $1.9B | $2B | $1.9B | $1.5B | $1.8B | |
Cash Acquisitions | -$2.4B | -- | $11M | -$102M | $138M | |
Cash From Investing | -$4.9B | -$1.5B | -$2B | -$1.8B | -$1.9B | |
Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.5B | -$3.2B | -$1.6B | -$1.7B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $7.1B | -- | -- | $500M | $744M | |
Long-Term Debt Repaid | -$3.4B | -$3.9B | -$4M | -$625M | -$776M | |
Repurchase of Common Stock | -$4M | -$463M | -$420M | -$211M | -$195M | |
Other Financing Activities | -$72M | -$215M | $263M | -$4M | $52M | |
Cash From Financing | $2.3B | -$6.4B | -$3.4B | -$2B | -$1.9B | |
Beginning Cash (CF) | $888M | $1.8B | $1.5B | $2.2B | $3.4B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $769M | -$192M | $735M | $1.2B | $71M | |
Ending Cash (CF) | $1.8B | $1.5B | $2.2B | $3.4B | $3.4B | |
Levered Free Cash Flow | $1.5B | $5.7B | $4.2B | $3.4B | $2B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.1B | $1.6B | $715M | $924M | -- | |
Depreciation & Amoritzation | $330M | $304M | $391M | $387M | -- | |
Stock-Based Compensation | $16M | $19M | $24M | $19M | -- | |
Change in Accounts Receivable | -$909M | -$200M | $87M | $113M | -- | |
Change in Inventories | -$181M | -$298M | -$30M | -$227M | -- | |
Cash From Operations | $1.9B | $1.6B | $1.3B | $1.3B | -- | |
Capital Expenditures | $431M | $532M | $301M | $484M | -- | |
Cash Acquisitions | -$104M | -- | -$2M | $188M | -- | |
Cash From Investing | -$303M | -$578M | -$371M | -$313M | -- | |
Dividends Paid (Ex Special Dividend) | -$378M | -$2.1B | -$408M | -$438M | -- | |
Special Dividend Paid | -- | $5.2M | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $500M | -- | -- | |
Long-Term Debt Repaid | -$1.3B | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$45M | -$100M | -$75M | -- | |
Other Financing Activities | -$35M | $185M | -$16M | $32M | -- | |
Cash From Financing | -$1.7B | -$1.7B | -$224M | -$481M | -- | |
Beginning Cash (CF) | $1.5B | $1.8B | $1.8B | $2.3B | -- | |
Foreign Exchange Rate Adjustment | $9M | -$70M | -$5M | -$21M | -- | |
Additions / Reductions | -$89M | -$658M | $695M | $554M | -- | |
Ending Cash (CF) | $1.4B | $1.1B | $2.5B | $2.9B | -- | |
Levered Free Cash Flow | $1.5B | $1.1B | $989M | $864M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.4B | $5.9B | $3B | $2.1B | $1.1B | |
Depreciation & Amoritzation | $1.4B | $1.4B | $1.4B | $1.5B | $1.5B | |
Stock-Based Compensation | $58M | $65M | $76M | $101M | $92M | |
Change in Accounts Receivable | -$843M | -$1.6B | $1.4B | -$328M | $404M | |
Change in Inventories | -$141M | -$499M | -$293M | $229M | -$65M | |
Cash From Operations | $3.4B | $8.6B | $5.1B | $4.3B | $3.4B | |
Capital Expenditures | $1.6B | $2.1B | $1.8B | $1.7B | $1.8B | |
Cash Acquisitions | -$2.4B | -- | $11M | -$102M | $138M | |
Cash From Investing | -$4.3B | -$1.9B | -$1.9B | -$1.9B | -$1.8B | |
Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.5B | -$3.3B | -$1.6B | -$1.7B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $1.2B | -- | |
Long-Term Debt Repaid | -$3.9B | -- | -- | -$1.4B | -$1M | |
Repurchase of Common Stock | -- | -$680M | -$273M | -$141M | -$305M | |
Other Financing Activities | $275M | -$241M | $201M | $41M | $21M | |
Cash From Financing | $605M | -$6.3B | -$3.2B | -$1.9B | -$2B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$264M | $411M | $36M | $545M | -$449M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $1.8B | $6.6B | $3.3B | $2.7B | $1.5B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $3.1B | $3B | $1.2B | $1.4B | $177M | |
Depreciation & Amoritzation | $665M | $615M | $787M | $752M | $323M | |
Stock-Based Compensation | $35M | $37M | $48M | $53M | $35M | |
Change in Accounts Receivable | -$1.5B | -$829M | -$192M | -$604M | -$440M | |
Change in Inventories | -$541M | -$415M | -$349M | -$335M | -$198M | |
Cash From Operations | $2.5B | $3.1B | $1.8B | $1.2B | -$579M | |
Capital Expenditures | $771M | $978M | $653M | $967M | $483M | |
Cash Acquisitions | -$104M | -- | -$2M | $188M | -- | |
Cash From Investing | -$362M | -$1B | -$742M | -$823M | -$430M | |
Dividends Paid (Ex Special Dividend) | -$730M | -$2.5B | -$797M | -$846M | -$433M | |
Special Dividend Paid | -- | $5.2M | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $500M | $744M | -- | |
Long-Term Debt Repaid | -$1.8B | -- | -- | -$775M | -- | |
Repurchase of Common Stock | -- | -$262M | -$170M | -$75M | -$110M | |
Other Financing Activities | $35M | $229M | -$34M | $59M | -$4M | |
Cash From Financing | -$2.5B | -$2.4B | -$701M | -$893M | -$547M | |
Beginning Cash (CF) | $3.2B | $3.3B | $4B | $5.7B | $3.4B | |
Foreign Exchange Rate Adjustment | -$23M | -$86M | $9M | -$59M | $38M | |
Additions / Reductions | -$359M | -$325M | $329M | -$482M | -$1.6B | |
Ending Cash (CF) | $2.8B | $2.9B | $4.3B | $5.2B | $1.9B | |
Levered Free Cash Flow | $1.7B | $2.1B | $1.1B | $267M | -$1.1B |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.